Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: A systematic review

Sleep Medicine Reviews

Volumn 18, Issue 1, 2014, Pages 49-59

  Kendzerska, Tetyana ^a   Mollayeva, Tatyana ^b   Gershon, Andrea S ^c   Leung, Richard S ^d   Hawker, Gillian ^e   Tomlinson, George ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

Cardiovascular events; Depression; Diabetes; Mortality; Obstructive sleep apnea; Prognostic review

Indexed keywords

ADVERSE OUTCOME; AGE DISTRIBUTION; APNEA HYPOPNEA INDEX; AROUSAL; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CORONARY ARTERY DISEASE; DAYTIME SOMNOLENCE; DEATH; DEPRESSION; DIABETES MELLITUS; FOLLOW UP; HUMAN; HYPOXEMIA; MORTALITY; POLYSOMNOGRAPHY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SLEEP TIME; SYSTEMATIC REVIEW;

CARDIOVASCULAR EVENTS; DEPRESSION; DIABETES; MORTALITY; OBSTRUCTIVE SLEEP APNEA; PROGNOSTIC REVIEW;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84890243008     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2013.01.003     Document Type: Review

References (66)

1. Epstein L.J., Kristo D., Strollo P.J., Friedman N., Malhotra A., Patil S.P., et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. JClin Sleep Med 2009, 5:263-276.
2. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. NEngl J Med 1993, 328:1230-1235.
3. Evans J.R.C., McRae L., Driver H., Fleetham J. The prevalence rate and risk of obstructive sleep apnea in Canada. Chest 2010, 138. (4_MeetingAbstracts):702A-702A.
4. Bradley T.D., Floras J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009, 373:82-93.
5. Bagai K. Obstructive sleep apnea, stroke, and cardiovascular diseases. Neurologist 2010, 16:329-339.
6. Tasali E., Ip M.S. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 2008, 5:207-217.
7. Knoepke Ca, Mark A. Proposed mechanisms of cognitive dysfunction in obstructive sleep apnea. Prim Psychiatry 2009, 16:51-56.
8. Sharma S., Kavuru M. Sleep and metabolism: an overview. Int J Endocrinol 2010.
9. Leung R.S., Comondore V.R., Ryan C.M., Stevens D. Mechanisms of sleep-disordered breathing: causes and consequences. Pflugers Arch 2012, 463:213-230.
10. Marshall N.S., Wong K.K., Liu P.Y., Cullen S.R., Knuiman M.W., Grunstein R.R. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008, 31:1079-1085.
11. He J., Kryger M.H., Zorick F.J., Conway W., Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988, 94:9-14.
12. Gottlieb D.J., Yenokyan G., Newman A.B., O'Connor G.T., Punjabi N.M., Quan S.F., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010, 122:352-360.
13. Ancoli-Israel S., DuHamel E.R., Stepnowsky C., Engler R., Cohen-Zion M., Marler M. The relationship between congestive heart failure, sleep apnea, and mortality in older men. Chest 2003, 124:1400-1405.
14. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
15. Arzt M., Young T., Finn L., Skatrud J.B., Bradley T.D. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005, 172:1447-1451.
16. Young T., Finn L., Peppard P.E., Szklo-Coxe M., Austin D., Nieto F.J., et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008, 31:1071-1078.
17. Newman A.B., Nieto F.J., Guidry U., Lind B.K., Redline S., Pickering T.G., et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001, 154:50-59.
18. Redline S., Yenokyan G., Gottlieb D.J., Shahar E., O'Connor G.T., Resnick H.E., et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010, 182:269-277.
19. Yaggi H.K., Concato J., Kernan W.N., Lichtman J.H., Brass L.M., Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. NEngl J Med 2005, 353:2034-2041.
20. Reichmuth K.J., Austin D., Skatrud J.B., Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005, 172:1590-1595.
21. Marshall N.S., Wong K.K., Phillips C.L., Liu P.Y., Knuiman M.W., Grunstein R.R. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study?. JClin Sleep Med 2009, 5:15-20.
22. Peppard P.E., Szklo-Coxe M., Hla K.M., Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med 2006, 166:1709-1715.
23. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., et al. Sleep apnea and cardiovascular disease: an American heart association/American college of cardiology foundation scientific statement from the American heart association council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. JAm Coll Cardiol 2008, 52:686-717.
24. Altman D.G. Systematic reviews of evaluations of prognostic variables. BMJ 2001, 323:224-228.
25. Hartling L, Bond K, Harvey K, Santaguida PL, Viswanathan M, Dryden DM. In: Developing and testing a tool for the classification of study designs in systematic reviews of interventions and exposures. Rockville (MD); 2010.
26. Hayden J.A., Cote P., Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006, 144:427-437.
27. Scottish Intercollegiate Guidelines Network. Published guidelines at on 05 September 2012. http://www.sign.ac.uk/guidelines/.
28. Gooneratne N.S., Richards K.C., Joffe M., Lam R.W., Pack F., Staley B., et al. Sleep disordered breathing with excessive daytime sleepiness is a risk factor for mortality in older adults. Sleep 2011, 34:435-442.
29. Munoz R., Duran-Cantolla J., Martinez-Vila E., Gallego J., Rubio R., Aizpuru F., et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006, 37:2317-2321.
30. Buchner N.J., Sanner B.M., Borgel J., Rump L.C. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 2007, 176:1274-1280.
31. Nakamura H.K.T., Takara C., Tsukayama A., Tohyama K., Matsumoto T., Iseki K. Aretrospective analysis of 4000 patients with obstructive sleep apnea in Okinawa, Japan. Sleep Biol Rhythms 2009, 7:103-112.
32. Punjabi N.M., Caffo B.S., Goodwin J.L., Gottlieb D.J., Newman A.B., O'Connor G.T., et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6:e1000132.
33. Shah N.A., Yaggi H.K., Concato J., Mohsenin V. Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath 2010, 14:131-136.
34. Chami H.A., Resnick H.E., Quan S.F., Gottlieb D.J. Association of incident cardiovascular disease with progression of sleep-disordered breathing. Circulation 2011, 123:1280-1286.
35. Cordero-Guevara J., Joaquín T.-S., Alonso-Álvarez María Luz, Castrodeza-Sanz Javier, Ordax-Carbajo Estrella, Masa-Jiménez Fernando Effectiveness of nasal continuous positive airway pressure (CPAP) therapy on cardiovascular outcomes in obstructive sleep apnea-hypopnea syndrome (OSAHS). Curr Resp Med Rev 2011, 7:121-129.
36. Campos-Rodriguez F., Pena-Grinan N., Reyes-Nunez N., De la Cruz-Moron I., Perez-Ronchel J., De la Vega-Gallardo F., et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005, 128:624-633.
37. Lavie P., Lavie L., Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 2005, 25:514-520.
38. Lavie P., Herer P., Lavie L. Mortality risk factors in sleep apnoea: a matched case-control study. JSleep Res 2007, 16:128-134.
39. Lavie P., Lavie L. Unexpected survival advantage in elderly people with moderate sleep apnoea. JSleep Res 2009, 18:397-403.
40. Marti S., Sampol G., Munoz X., Torres F., Roca A., Lloberes P., et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002, 20:1511-1518.
41. Doherty L.S., Kiely J.L., Swan V., McNicholas W.T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005, 127:2076-2084.
42. Peker Y., Hedner J., Norum J., Kraiczi H., Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002, 166:159-165.
43. Peker Y., Carlson J., Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006, 28:596-602.
44. Iber C., A-I S., Chesson A., Quan S.F. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specification 2007, for the American Academy of Sleep Medicine, American Academy of Sleep Medicine, Westchester, Illinois. 1st ed.
45. Ronksley P.E., Hemmelgarn B.R., Heitman S.J., Hanly P.J., Faris P.D., Quan H., et al. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 2009, 64:834-839.
46. Hedner J., Grote L., Bonsignore M., McNicholas W., Lavie P., Parati G., et al. The European sleep apnoea database (ESADA): report from 22 European sleep laboratories. Eur Respir J 2011, 38:635-642.
47. Lin E.D.-G.N., Stewart D., Rhodes A., Yeritsyan N., Johns A., Duong-Hua M., et al. Depression. Project for an Ontario Women's health evidence-based report 2009, vol. 1. Toronto.
48. Coyne J.C., Schwenk T.L., Fechner-Bates S. Nondetection of depression by primary care physicians reconsidered. Gen Hosp Psychiatry 1995, 17:3-12.
49. Sanchez-Villegas A., Schlatter J., Ortuno F., Lahortiga F., Pla J., Benito S., et al. Validity of a self-reported diagnosis of depression among participants in a cohort study using the Structured Clinical Interview for DSM-IV (SCID-I). BMC Psychiatry 2008, 8:43.
50. Wilcox I., McNamara S.G., Collins F.L., Grunstein R.R., Sullivan C.E. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998, 53:S25-S28.
51. An epidemic of risk factors for cardiovascular disease. Lancet 2011, 377(9765):527.
52. Anand S.S., Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet 2011, 377:529-532.
53. Chia Y.C. Review of tools of cardiovascular disease risk stratification: interpretation, customisation and application in clinical practice. Singapore Med J 2011, 52:116-123.
54. Berry J.D., Dyer A., Cai X., Garside D.B., Ning H., Thomas A., et al. Lifetime risks of cardiovascular disease. NEngl J Med 2012, 366:321-329.
55. Punjabi N.M., Newman A.B., Young T.B., Resnick H.E., Sanders M.H. Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopneas. Am J Respir Crit Care Med 2008, 177:1150-1155.
56. Leung R.S., Bradley T.D. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001, 164:2147-2165.
57. Newman A.B., Arnold A.M., Naydeck B.L., Fried L.P., Burke G.L., Enright P., et al. "Successful aging": effect of subclinical cardiovascular disease. Arch Intern Med 2003, 163:2315-2322.
58. Steiner S., Schueller P.O., Schulze V., Strauer B.E. Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest 2010, 137:516-520.
59. Lavie L., Lavie P. Coronary collateral circulation in sleep apnea: a cardioprotective mechanism?. Chest 2010, 137:511-512.
60. Mokhlesi B., Kryger M.H., Grunstein R.R. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc 2008, 5:218-225.
61. Glaab T., Vogelmeier C., Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res 2010, 11:79.
62. Ferreira-Gonzalez I., Busse J.W., Heels-Ansdell D., Montori V.M., Akl E.A., Bryant D.M., et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ 2007, 334:786.
63. Stoohs R., Guilleminault C. Snoring during NREM sleep: respiratory timing, esophageal pressure and EEG arousal. Respir Physiol 1991, 85:151-167.
64. Platt A.B., Kuna S.T., Field S.H., Chen Z., Gupta R., Roche D.F., et al. Adherence to sleep apnea therapy and use of lipid-lowering drugs: a study of the healthy-user effect. Chest 2010, 137:102-108.
65. Villar I., Izuel M., Carrizo S., Vicente E., Marin J.M. Medication adherence and persistence in severe obstructive sleep apnea. Sleep 2009, 32:623-628.
66. Chapter 10: Addressing reporting biases. Cochrane handbook for systematic reviews of interventions. Version 5.0.1 2008, The Cochrane Collaboration, [updated September 2008]. J.A.C. Sterne, M. Egger, D. Moher (Eds.).